Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114126

Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.

R W Mahley, K H Weisgraber, M M Hussain, B Greenman, M Fisher, T Vogel, and M Gorecki

Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140.

Find articles by Mahley, R. in: JCI | PubMed | Google Scholar

Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140.

Find articles by Weisgraber, K. in: JCI | PubMed | Google Scholar

Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140.

Find articles by Hussain, M. in: JCI | PubMed | Google Scholar

Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140.

Find articles by Greenman, B. in: JCI | PubMed | Google Scholar

Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140.

Find articles by Fisher, M. in: JCI | PubMed | Google Scholar

Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140.

Find articles by Vogel, T. in: JCI | PubMed | Google Scholar

Gladstone Foundation Laboratories for Cardiovascular Disease, University of California, San Francisco 94140.

Find articles by Gorecki, M. in: JCI | PubMed | Google Scholar

Published June 1, 1989 - More info

Published in Volume 83, Issue 6 on June 1, 1989
J Clin Invest. 1989;83(6):2125–2130. https://doi.org/10.1172/JCI114126.
© 1989 The American Society for Clinical Investigation
Published June 1, 1989 - Version history
View PDF
Abstract

Plasma cholesterol levels in cholesterol-fed rabbits were markedly reduced by the intravenous infusion or bolus injection of recombinant human apo E or rabbit plasma apo E. Administration of 6-70 mg of apo E resulted in an approximately 20-40% acute reduction in plasma cholesterol levels within 2-3 h. Plasma cholesterol levels remained reduced for 4-8 h after the administration of apo E. Furthermore, the intravenous injection of apo E reduced the plasma cholesterol levels in Watanabe heritable hyperlipidemic rabbits. The addition of apo E to [14C]cholesterol-labeled canine thoracic duct lymph or [14C]cholesterol-labeled chylomicrons resulted in accelerated plasma clearance of these diet-induced lipoproteins in normal rabbits, with the uptake occurring primarily in the liver. This study suggests that the amount or availability of apo E in the plasma of cholesterol-fed rabbits may be rate limiting for the normal clearance of diet-induced remnant lipoproteins.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2125
page 2125
icon of scanned page 2126
page 2126
icon of scanned page 2127
page 2127
icon of scanned page 2128
page 2128
icon of scanned page 2129
page 2129
icon of scanned page 2130
page 2130
Version history
  • Version 1 (June 1, 1989): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts